 |
Previous Article | Next Article 
The Journal of Neuroscience, April 15, 2001, 21(8):2589-2599
The Surface Accessibility of the Glycine Receptor M2-M3 Loop Is
Increased in the Channel Open State
Joseph W.
Lynch1,
Nian-Lin Reena
Han1,
Justine
Haddrill1,
Kerrie
D.
Pierce2, and
Peter R.
Schofield2
1 Department of Physiology and Pharmacology, University
of Queensland, Brisbane, QLD, 4072, Australia, and
2 Neurobiology Program, Garvan Institute of Medical
Research, Darlinghurst, Sydney, NSW, 2010, Australia
 |
ABSTRACT |
Mutations in the extracellular M2-M3 loop of the glycine
receptor (GlyR) 1 subunit have been shown previously to affect
channel gating. In this study, the substituted cysteine accessibility method was used to investigate whether a structural rearrangement of
the M2-M3 loop accompanies GlyR activation. All residues from R271C to
V277C were covalently modified by both positively charged methanethiosulfonate ethyltrimethylammonium (MTSET) and negatively charged methanethiosulfonate ethylsulfonate (MTSES), implying that
these residues form an irregular surface loop. The MTSET modification
rate of all residues from R271C to K276C was faster in the
glycine-bound state than in the unliganded state. MTSES modification of
A272C, L274C, and V277C was also faster in the glycine-bound state.
These results demonstrate that the surface accessibility of the M2-M3
loop is increased as the channel transitions from the closed to the
open state, implying that either the loop itself or an overlying domain
moves during channel activation.
Key words:
ligand-gated ion channel; glycine receptor 1 subunit; substituted cysteine accessibility method (SCAM); methanethiosulfonate
ethyltrimethylammonium (MTSET); methanethiosulfonate ethylsulfonate
(MTSES); hyperekplexia
 |
INTRODUCTION |
The inhibitory glycine receptor
(GlyR) chloride channel mediates inhibitory neurotransmission in the
spinal cord and brainstem. GlyRs are members of the
neurotransmitter-gated ion channel superfamily, which also includes
nicotinic, serotonin, and GABAA- and
GABAC-type receptors (Galzi and Changeux, 1995 ;
Karlin and Akabas, 1995 ; Rajendra et al., 1997 ). Receptors of this
family are composed of five subunits arranged symmetrically around a
central ion-conducting pore. Individual subunits consist of a large
extracellular N-terminal domain that contains ligand-binding sites and
four membrane-spanning domains (M1-M4). The M2 domain forms an
-helix that lines the channel pore. The ligand-binding sites are
distant from the channel activation gate, implying that channel
activation is mediated by long-range allosteric mechanisms. However,
little is known about the structural basis of these interactions.
Human hereditary hyperekplexia, or startle disease, is caused by
mutations in both the intracellular and extracellular loops flanking
the M2 domain (Shiang et al., 1993 , 1995 ; Rees et al., 1994 ; Elmslie et
al., 1996 ; Saul et al., 1999 ). It has been demonstrated recently that
both startle disease mutations and many alanine-substitution mutations
distributed throughout the M1-M2 and M2-M3 loops uncouple agonist-binding sites from the channel activation gate (Rajendra et
al., 1995a ; Lynch et al., 1997 ; Lewis et al., 1998 ; Saul et al., 1999 ).
These results suggest a role for these loops in the channel-gating
process. However, it remains to be established whether channel
activation is accompanied by physical changes in the conformation of
these loops.
The scanning cysteine accessibility method can be used to identify
structural changes of ion channel domains in different functional
states (Karlin and Akabas, 1998 ). In this technique, cysteine residues
are probed with a water-soluble, cysteine-specific methanethiosulfonate
(MTS) derivative. If a functional property of the channel is
irreversibly modified on exposure to such a reagent, the cysteine is
assumed to be exposed at the water-accessible protein surface. The rate
of reaction with cysteines is determined by the local electrostatic
potential, sulfhydryl ionization state, and steric accessibility of the
sulfhydryl group at the protein surface (Karlin and Akabas, 1998 ). If
the modification rate difference between the closed and open states is
similar for both a positively charged and a negatively charged MTS
reagent, then state-dependent changes in electrostatic potential can be
eliminated. In such a case, the reaction rate is assumed to be
dominated by the ionization state and steric accessibility, which both
increase with thiol exposure to the aqueous interface (Karlin and
Akabas, 1998 ).
We applied this approach in an attempt to determine whether
structural rearrangements in the M2-M3 loop accompany GlyR channel activation. This study compares the open and closed state reaction rates of positively charged MTS-ethyltrimethylammonium (MTSET) and
negatively charged MTS-ethylsulfonate (MTSES) (Stauffer and Karlin,
1994 ). We concluded that the seven residues closest to the M2 end of
the loop are accessible to the aqueous environment. Furthermore, the
state-dependent differences in the reaction rates of both MTSET and
MTSES imply that either the loop itself or an overlying domain must
move during channel activation.
 |
MATERIALS AND METHODS |
Mutagenesis and expression of human GlyR
1 subunit cDNA. Site-directed mutations were
incorporated into the human GlyR 1 subunit cDNA in the pCIS2
expression vector using oligonucleotide-driven PCR mutagenesis and were
confirmed by sequencing the cDNA clones. All cysteine-substituted
mutant GlyRs investigated in this study also incorporated the C41A
mutation. Wild-type (WT) and mutant plasmid constructs were transiently
transfected into the human embryonic kidney 293 cell line using the
modified calcium phosphate precipitation method (Chen and Okayama,
1987 ). After 24 hr exposure to transfecting solution, cells were washed
with culture medium (Eagle's minimum essential medium supplemented
with 2 mM glutamine and 10% fetal calf serum),
and patch-clamp studies were conducted over the following 24-72 hr.
Electrophysiology. Glycine-gated currents were recorded
using the whole-cell patch-clamp configuration at a holding potential of 50 mV. Currents were recorded directly to disk via an Axopatch 1D
amplifier and pClamp6 software (Axon Instruments, Foster City, CA).
Coverslips containing cultured transfected cells were transferred into
a small volume (2 ml) recording chamber that was continually perfused
at ~2 ml/min with the standard bathing solution containing (in
mM): 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES,
10 glucose, pH 7.4, with NaOH. Heat-polished patch pipettes had tip
resistances of 1-2.5 M when filled with the standard intracellular
solution containing (in mM): 145 CsCl, 2 CaCl2, 2 MgCl2, 10 HEPES,
10 EGTA, pH 7.4, with CsOH. At least 50% of full series resistance
compensation was applied in all recordings. MTSET and MTSES, obtained
from Toronto Research Chemicals (Toronto, Canada), were prepared as stock solutions of 10 and 100 mM, respectively,
in distilled water and maintained on ice for up to 3 hr until used.
These compounds were applied to cells within 30 sec of being dissolved
in room temperature bathing solution. The disulfide reducing agent,
dithiothreitol (DTT), was prepared daily as a 1 mM solution (unless otherwise indicated) in the
standard bathing solution. This DTT-containing solution had no effect
on the magnitude of currents in the WT GlyR. Solutions were applied to
cells via a parallel system of gravity-fed tubes, and solution exchange
was effected with a time constant of ~100 msec. Experiments were
performed at room temperature (19-22°C).
The effects of MTSET and MTSES were tested using the following
procedure. After establishment of the recording configuration, cells
were bathed in 1 mM DTT for 1 min to ensure that exposed sulfhydryl groups were fully reduced. Then the glycine dose-response was measured by applying increasing glycine concentrations at 1 min
intervals. After this, three consecutive brief applications of a
constant glycine concentration were applied at 1 min intervals to
establish that the current magnitude was invariant. Provided that the
current amplitude remained constant (±5%), the averaged maximum
current amplitude was used as the control. After application of the
MTS-containing solution, cells were washed in control solution for at
least 2 min before the maximum current magnitudes and glycine EC50 values were measured again. In long-term
patch recordings, both parameters were measured continually and were
observed to remain constant in all mutant GlyRs for periods as long as
40 min. This strongly suggests that irreversible changes in both parameters were caused by covalent modification of exposed cysteines. Initial screening of cysteine-substituted mutant GlyRs comprised a 1 min application of either 100 µM MTSET or 1 mM MTSES. It is estimated that a 10% irreversible change
in current over 1 min would have been reliably detected. If an
irreversible effect was observed, the concentration of the MTS
derivative was adjusted so that the time constant of the current
response was between 0.5 and 20 sec. The method used to measure the MTS
modification rate is explained in the text. The receptor
desensitization rate was low (<0.005
sec 1) for all mutant GlyRs used
in this study and, as such, did not impact significantly on the
measurement of MTS reactivity rates.
Data analysis. Results are expressed as mean ± SEM of three or more independent experiments. The empirical Hill
equation, fitted by a nonlinear least-squares algorithm (Sigmaplot;
Jandel Scientific, San Rafael, CA), was used to calculate the 50%
effective concentrations for activation (EC50).
There was no consistent relationship between the respective Hill
coefficient values and any other parameter measured in this study.
Exponential fits were performed using the same nonlinear least-squares
algorithm. Statistical significance was determined by one-way ANOVA
using the Student-Newman-Keuls post hoc test for unpaired
data (Sigmastat; Jandel Scientific), with p < 0.05 representing significance.
 |
RESULTS |
Effect of MTSET and MTSES on the WT GlyR
The effect of 100 µM MTSET in the presence of a
half-maximal (20 µM) concentration of glycine on the WT
GlyR is shown in Figure 1A. The three traces
were recorded at 2 min intervals from the same cell. The center trace
shows that MTSET induces a transient increase in glycine current, but
this effect is rapidly reversed on the removal of MTSET. The control
glycine trace recorded after a 2 min wash in control bathing solution
confirms the absence of a sustained MTSET effect (Fig.
1A, right). Similarly, 100 µM MTSET had no irreversible effect when
applied in the absence of glycine. Figure 1B
demonstrates that MTSET acts as a weak reversible agonist of the
receptor. Furthermore, immediately after MTSET exposure, the
glycine-gated current was transiently increased, possibly because of
the effect observed in Figure 1A. However, a control
glycine-gated current recorded several seconds later confirms that this
transient current increase was not sustained. These experiments, which
were repeated in a total of four cells, confirm that 100 µM MTSET induced no significant irreversible change in current magnitude, regardless of whether it was applied in
the absence or presence of glycine. Similarly, a 1 mM concentration of MTSET also caused no
irreversible effect at either a half-saturating (20 µM) or a saturating (1 mM) concentration of glycine (n = 3 cells). An example of the effect of 1 mM MTSET in
the presence of 1 mM glycine is shown in Figure
1C.

View larger version (22K):
[in this window]
[in a new window]
|
Figure 1.
Effect of MTSET on the WT GlyR. A,
All traces represent currents activated by a
half-saturating (20 µM) concentration of glycine. In this
and all subsequent figures, the dashed line indicates
the channel closed state; unless otherwise indicated, glycine
applications are indicated by unfilled bars, and MTSET
applications are indicated by filled bars. The three
traces were recorded at 2 min intervals from the same
cell. The left trace is a control glycine-gated current.
The center trace shows the response to 100 µM MTSET applied in conjunction with 20 µM
glycine. The right trace was recorded after a 2 min wash
in the standard bathing solution. B, This
trace was recorded from the same cell as A.
The first two glycine applications were separated by an ~20 sec
application of MTSET alone. The dotted line is included
to emphasize the transient increase in glycine-activated current after
MTSET exposure. C, In this cell, a saturating (1 mM) glycine concentration was used to maximally activate
all available channels. A 1 mM MTSET concentration appeared
to have no effect on current magnitude. A control glycine-activated
current recorded after a 2 min wash in standard bathing solution
confirms this (right trace).
|
|
The transient potentiation induced by MTSET was dramatically diminished
at saturating glycine concentrations (Fig. 1C), implying that it was predominantly mediated by an enhancement of the apparent glycine affinity. The agonist action of MTSET was characterized by an
extremely slow onset, with maximal activation requiring an MTSET
application time of >10 sec. Both the potentiation and the activation
were observed sporadically in all mutant GlyRs examined in this study.
Their magnitudes diminished rapidly with repeated applications of the
same MTSET solution, implying that they were mediated by MTSET itself
and not its breakdown products. These reversible effects of MTSET were
not investigated further. However, because the magnitudes of the
reversible effects were much smaller than those of the irreversible
effects, they did not impact significantly on the measurements of MTSET
reaction rates.
The effects of 1 mM MTSES on the WT GlyR were very similar
to those of MTSET. MTSES also acted as a weak partial agonist in the
absence of glycine and induced reversible potentiation in the presence
of glycine. However, as summarized below (see Fig. 8), it exerted no
irreversible effects on the GlyR, regardless of whether it was applied
in the absence or presence of glycine.
Despite the absence of irreversible MTSET or MTSES effects on the WT
GlyR, it is possible that introduction of a cysteine mutation could
expose a previously concealed cysteine elsewhere in the protein (Karlin
and Akabas, 1998 ). Hence, it is necessary to remove any uncross-linked
external cysteines to avoid possible complications in the
interpretation of results obtained with cysteine-modifying agents
(Karlin and Akabas, 1998 ). The human GlyR 1 subunit contains five
external endogenous cysteines. However, in the recombinantly expressed
receptor, four of these cysteines are cross-linked. Disulfide bonds are
formed between C138-C152 and C198-C209 (Rajendra et al., 1995b ). The
remaining cysteine at position 41 is not believed to be cross-linked,
and, hence, all cysteine-substituted mutant GlyRs examined in this
study were constructed on the background of the C41A mutation. As shown
in Figure 2, the C41A mutation caused no
change in either the glycine EC50 value or the
magnitude of peak currents.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 2.
Properties of the WT and mutant GlyRs used
in this study. Note that all cysteine-substituted GlyRs were
constructed on the background of the C41A mutation. A,
Examples of averaged glycine dose-responses from the WT GlyR ( ),
the S273C mutant GlyR ( ), the K276C mutant GlyR ( ), and the V280C
mutant GlyR ( ). B, Summary of glycine dose-response
data. All points are averaged from three to six different cells, and
error bars (± SEM) are shown when larger than symbol size. The
horizontal line is drawn through the mean WT glycine
EC50 value. C, Maximum currents activated at
saturating glycine concentrations. Each bar represents the average of
three to nine cells.
|
|
Exposure of the WT GlyR for 1 min to a 1 mM concentration
of the reducing agent, DTT, had no effect on current magnitude. This
implies that the endogenous disulfide bonds are either not exposed at
the protein surface or not needed for receptor activation by glycine
after the receptor is inserted into the membrane. As described below,
this concentration of DTT was able to completely reduce the disulfide
bonds formed between MTSET and the exposed introduced cysteines.
Steady-state effects of MTSET on mutant GlyRs
The substituted cysteine accessibility method (Karlin and Akabas,
1998 ) was used to investigate the pattern of residue accessibility of
the M2-M3 loop in both the open and closed channel states. Accordingly, the 11 residues forming the N-terminal portion of this
loop (R271-K281) were individually mutated to cysteine on the
background of the C41A mutation. With the exception of Y279C, all
mutant GlyRs produced large glycine-gated inward currents in cells
voltage-clamped at 50 mV. The Y279C mutation, which is a genetic
cause of human startle disease (Shiang et al., 1995 ), has been shown
previously to dramatically reduce the whole-cell glycine-gated
conductance (Lynch et al., 1997 ). Representative glycine dose-response
curves for the WT and several mutant GlyRs are displayed in Figure
2A. The averaged glycine EC50
values and peak current magnitudes for the WT and all mutant GlyRs are
shown in Figure 2, B and C, respectively. As seen
in Figure 2B, some mutations caused glycine
EC50 changes of up to 100 times that of the WT
GlyR and therefore may have induced nonspecific structural alterations
in the M2-M3 loop. The implications of this for the interpretation of
results are considered below.
Examples of MTSET effects on the S273C mutant GlyR are shown in Figure
3. In Figure 3A, it can be
seen that MTSET applied in the closed state caused a strong
potentiation of the glycine-gated current (left). In this
experiment, glycine was applied at the concentration of 20 µM, which corresponds approximately to its EC20 value. Because the MTSET-induced
potentiation persisted after a 2 min wash (Fig. 3A,
center), it was concluded that it was caused by covalent
modification of the introduced cysteine. The potentiation was
completely reversed by a 1 min wash in a 1 mM
DTT-containing solution (right).

View larger version (22K):
[in this window]
[in a new window]
|
Figure 3.
Effect of MTSET on the S273C mutant GlyR.
A, All traces in A and
B were recorded sequentially from the same cell in the
presence of 20 µM glycine. This glycine concentration
corresponds approximately to the EC20. The left
trace shows the effect of an ~50 sec application of 100 µM MTSET alone. The center trace shows
that the current increase remains after a 2 min wash in standard
bathing solution. The right trace shows that a 1 min
wash in 1 mM DTT solution returns the current magnitude to
the control level. B, The left trace
shows the effect of applying MTSET in the presence of glycine. The
center trace was recorded after a 2 min wash in standard
bathing solution, and the right trace was recorded after
a 1 min exposure to 1 mM DTT. C, The
left trace shows that when glycine is applied at a
saturating (1 mM) concentration, there is no effect of
MTSET on peak current magnitude. The right trace is a
control recorded after a 2 min wash in standard bathing solution.
|
|
When applied in the presence of 20 µM glycine, MTSET
caused a strong rapid potentiation (Fig. 3B,
left) that persisted after a 2 min wash (center).
Again, the potentiation was completely reversed by a 1 min DTT wash
(right). As summarized in Figure 4, there was no significant difference in
the magnitude of the MTSET-induced potentiation between the closed and
open channel states. However, when MTSET was applied in the presence of
a saturating (1 mM) glycine concentration, no
change in current magnitude was observed (Fig. 3C), although
receptor modification did occur (Fig. 5A). This indicates that MTSET
acted by increasing the apparent glycine affinity. This observation was
confirmed directly by measuring the glycine dose-responses before and
after the application of 100 µM MTSET. Examples
of glycine dose-responses in the S273C mutant GlyR in the same cell
before and after MTSET exposure are shown in Figure 5A. The
averaged respective glycine EC50 values are shown
in Figure 5B. As seen in this Figure, MTSET caused an approximately 10-fold increase in the apparent glycine affinity of the
S273C mutant GlyR.

View larger version (37K):
[in this window]
[in a new window]
|
Figure 4.
Summary of the effects of 100 µM
MTSET on glycine-activated currents in the WT and cysteine-substituted
mutant GlyRs. MTSET was applied for a sufficient time for the current
change to reach a steady-state value or for a period of 1 min,
whichever came first. The percentage change was calculated
as
(Iglycine,after/Iglycine,before 1) × 100. Light-shaded columns show the effect
of MTSET when applied in the absence of glycine. Dark-shaded
columns show the effect of MTSET when applied simultaneously
with glycine. All points were averaged from three to nine different
cells, and error bars (± SEM) are shown. The glycine concentrations
(together with the approximate EC value) that were used in these
experiments are as follows: WT, 20 µM
(EC50); R271C, 1 mM
(EC20); A272C, 1 mM
(EC20); S273C, 20 µM
(EC20); L274C, 200 µM
(EC20); P275C, 1 mM
(EC50); K276C, 1 mM
(EC20); V277C, 1 mM
(EC50); S278C, 100 µM
(EC50); Y279C, 1 mM
(EC20); V280C, 1 µM
(EC20); K281C, 20 µM
(EC20). Using a one-way ANOVA and
Student-Newman-Keuls post hoc test, we found that
MTSET caused highly significant (p < 0.01)
changes in current magnitude in the R271C, A272C, S273C, L274C, P275C,
and K276C mutant GlyRs, relative to the C41A mutant GlyR. However, the
magnitude of the current change was not significantly dependent on
whether MTSET was applied in the open or closed state.
|
|

View larger version (36K):
[in this window]
[in a new window]
|
Figure 5.
Effect of MTSET on the apparent glycine
affinity of mutant GlyRs. A, Examples of glycine
dose-responses from the S273C mutant GlyR measured before and after a
30 sec application of 100 µM MTSET. Both dose-responses
were recorded from the same cell. B, Averaged
dose-responses recorded before ( ) and after ( ) MTSET exposure
for all MTSET-reactive mutant GlyRs. Points represent the average of
three to four measurements, and error bars are shown when larger than
symbol size.
|
|
Using a similar experimental approach, we investigated the effects of
100 µM MTSET on all cysteine-substituted mutant GlyRs, and its effects on current magnitude are displayed in Figure 4. MTSET
was applied in both the absence and presence of glycine, with its
effects being monitored using both a subsaturating
(EC20-EC50) and a
saturating glycine concentration. MTSET was applied for sufficient time for the observed current magnitude changes to reach a
steady-state value or for a period of 1 min, whichever came first. The
subsaturating glycine concentrations, together with their respective EC
values, that were applied to each mutant GlyR are listed in the legend
to Figure 4. The EC20 glycine concentrations were
used on each of the mutant GlyRs in which MTSET had an irreversible potentiating effect. When using a saturating glycine concentration, we
observed no effect of MTSET on any mutant GlyR investigated in this
study. However, when assayed using the subsaturating glycine concentration, MTSET induced statistically significant
(p < 0.05) current magnitude changes, relative
to the C41A mutant GlyR, in the following six mutant GlyRs: R271C,
A272C, S273C, L274C, P275C, and K276C (Fig. 4).
Figure 4 demonstrates that the final effect of MTSET was independent of
whether it was applied in the channel closed or open state. It further
shows that MTSET induces an increase in apparent glycine
affinity in the R271C, A272C, S273C, L274C, and K276C mutant GlyRs and
a decrease in the apparent affinity in the P275C mutant GlyR. This was
confirmed by measuring the glycine dose-responses for each of these
mutant GlyRs before and after MTSET exposure (Fig. 5B). The
change in glycine sensitivity of each of the mutants displayed in this
Figure was statistically significant (p < 0.05).
Interestingly, neither MTSET nor MTSES had any significant effect on
the L274C mutant GlyR unless the receptor was reduced first by a 1 min
DTT application (n = 12 cells). Because this reaction did
not alter significantly the magnitude of the current activated by the
EC20 glycine concentration
(p > 0.05; n = 6), the DTT
application had no effect on the glycine affinity.
State-dependence of MTSET reaction rates
The state-dependence of MTSET reaction with S273C was measured as
shown in Figure 6. MTSET was applied
first in the closed state (Fig. 6A) and then in the
open state (Fig. 6B) in the same cell. After the
first MTSET application, a 1 min exposure to 1 mM
DTT was required to completely reduce the introduced cysteine before
MTSET was applied again. In both the closed and open states, experiments were performed using a 20 µM
(EC20) glycine concentration and a 100 µM MTSET concentration. To assess MTSET
reactivity in the closed state, the cell was rapidly switched between a
glycine-only solution and an MTSET-only solution (Fig.
6A). The relationship between the current magnitude
change and the cumulative MTSET exposure time for the trace
displayed in Figure 6A is plotted in Figure
6C ( ). The current-response to MTSET applied in the open
state (Fig. 6B) is directly replotted in Figure
6C. The time courses of the MTSET reaction rate in
both the open and closed states were described adequately by single
exponential fits with respective time constants of 0.61 sec (open
state) and 3.07 sec (closed state). The averaged open and closed state
reaction time constants were 0.54 ± 0.08 sec (n = 8 cells) and 3.51 ± 0.6 sec (n = 7), respectively. The
difference between these values was statistically significant
(p < 0.05). Thus, MTSET reacted ~6.5 times
faster in the open channel state than in the closed state.

View larger version (24K):
[in this window]
[in a new window]
|
Figure 6.
State-dependent MTSET modification of S273C.
A, To assess MTSET reactivity in the closed state, the
cell was rapidly switched between a solution that contained only 20 µM glycine and a solution that contained only 100 µM MTSET. Note the slow weak agonist action of MTSET in
this cell. B, Measurement of the effect of 100 µM MTSET in the open state. This trace was
recorded from the same cell as A (after a 1 min DTT
wash) and is plotted using the same horizontal and
vertical scales. C, Measurement of
reaction time constants in the closed and open states. The
filled circles represent the proportionate increase in
current magnitude plotted against cumulative exposure time to MTSET
applied in the closed state. The noisy current trace corresponding to
MTSET applied in the open state has been replotted from
B. Both final steady-state current amplitudes were
normalized to 1, and the initial current magnitudes were normalized to
zero. The lines represent exponential fits obtained
using a nonlinear least-squares fitting routine with the time constants
of best fit as shown.
|
|
One limitation to this approach is that, for most mutant GlyRs, the
"open state" MTSET reaction rate was measured at the glycine EC20 value. This was necessary because most
mutant GlyRs responded to MTSET via a dramatic increase in the glycine
affinity (Fig. 5B). If a higher EC value had been used,
the receptor current would have saturated before completion of the
MTSET reaction, thereby distorting the apparent modification rate.
Thus, in the open state, channels were open on average for only 20% of
the time that they would have been at a saturating glycine
concentration. Presumably, if a higher equivalent concentration had
been used, a faster MTSET reaction rate would have resulted.
Furthermore, assessment of the reaction rate in the closed state is
complicated by the fact that MTSET was often a weak agonist. Thus, the
true differential between reaction rates in the closed and open states is likely to be underestimated in these experiments.
The state-dependence of MTSET reactivity with the R271C, A272C, L274C,
P275C, and K276C mutant GlyRs was investigated using a similar
procedure, and the mean reaction rates thus obtained are displayed in
Figure 7A. As seen in this
Figure, the rate of reaction between MTSET and all residues from R271C
to K276C was significantly increased in the glycine-bound state.

View larger version (23K):
[in this window]
[in a new window]
|
Figure 7.
MTSET and MTSES reaction rates in the open ( )
and closed ( ) channel states. A, Averaged reaction
rates for MTSET. The MTSET and glycine concentrations used in these
determinations are given in the legend to Figure 4. B,
Averaged reaction rates for MTSES. The MTSES and glycine concentrations
used in these determinations are given in the legend to Figure 8. All
points are averaged from three to eight cells for each mutant GlyR.
Error bars are shown when larger than symbol size. Reaction rates were
significantly faster in the open state than in the closed state for all
displayed mutant GlyRs (p < 0.05).
|
|
Effects of MTSES on mutant GlyRs
The influence of electrostatic potential can be determined by
comparing the state-dependence of the reaction rate of negatively and
positively charged MTS derivatives (Pascual and Karlin, 1998 ). Accordingly, we investigated the effects of negatively charged MTSES on
the cysteine-substituted mutant GlyRs.
As shown in Figure 8, MTSES also induced
irreversible current magnitude changes in several mutant GlyRs. Figure
8, A and B, displays the mean amplitude changes
measured in the presence of subsaturating and saturating glycine
concentrations, respectively. MTSES was applied for sufficient time for
the observed current magnitude changes to reach a steady-state value or
for a maximum period of 1 min, whichever came first. The concentrations
of glycine and MTSES used in these experiments are displayed in the
legend to Figure 8. MTSES modification of A272C dramatically increased the current activated by a 1 mM
(EC20) glycine concentration but had no apparent
effect at a saturating (15 mM) glycine
concentration. However, the effect of MTSES on the K276C and V277C
mutant GlyRs was not significantly dependent on the glycine
concentration. It should be noted that although MTSES did modify
irreversibly the P275C mutant GlyR, its effect was not accompanied by a
change in the amplitude of the glycine-activated current (see below). Furthermore, because the L274C mutant GlyR was activated irreversibly by MTSES (see below), its effect could not be plotted on this scale.

View larger version (31K):
[in this window]
[in a new window]
|
Figure 8.
Summary of the effects of MTSES on
glycine-activated currents in the WT and cysteine-substituted mutant
GlyRs. The percentage change was calculated as
(Iglycine,after/Iglycine,before 1) × 100. MTSES was applied for a sufficient time for the
current change to reach a steady-state value or for a period of 1 min,
whichever came first. Light-shaded columns show the
effect of MTSES when applied in the absence of glycine.
Dark-shaded columns show the effect of MTSES when
applied simultaneously with glycine. All points were averaged from
three to nine different cells. A, The effect of MTSES at
a subsaturating glycine concentration. The glycine concentrations
(together with the approximate EC values) that were used in these
experiments were as follows: WT, 20 µM
(EC50); R271C, 1 mM
(EC20); A272C, 1 mM
(EC20); S273C, 20 µM
(EC20); L274C, 400 µM
(EC50); P275C, 1 mM
(EC50); K276C, 1 mM
(EC20); V277C, 1 mM
(EC50); S278C, 100 µM
(EC50); Y279C, 1 mM
(EC20); V280C, 1 µM
(EC20); K281C, 20 µM
(EC20). MTSES was applied at a concentration of 1 mM, except in the following mutants: A272C, 5 mM; K276C, 500 µM; V277C, 200 µM. MTSES induced significant
(p < 0.05) changes in current magnitude in
the A272C, K276C, and V277C mutant GlyRs, compared with the C41A mutant
GlyR, but there was no significant difference between the open and
closed states. B, The effect of MTSES at a saturating
glycine concentration. The glycine concentrations used are as follows:
WT, 1 mM; R271C, 15 mM; A272C, 15 mM; S273C, 1 mM; L274C, 10 mM;
P275C, 15 mM; K276C, 15 mM; V277C, 15 mM; S278C, 10 mM; Y279C, 15 mM;
V280C, 1 mM; K281C, 1 mM. The MTSES
concentrations used are as indicated in A. MTSES induced
significant (p < 0.05) changes in current
magnitude in the K276C and V277C mutant GlyRs. However, these values
were not significantly different from their respective values in
A.
|
|
Although MTSES did not appear to modify the R271C or S273C mutant
GlyRs, MTSET induced a large effect. Hence, by examining the effects of
sequential applications of MTSES and MTSES, it should be possible to
detect whether MTSES is able to covalently modify these mutant GlyRs.
An example of such an experiment designed to investigate this is shown
in Figure 9A. Before the
displayed experiment, the receptor was fully reduced by a 1 min
exposure to 1 mM DTT. As shown in Figure
9A, 1 mM MTSES induced no irreversible effect (top panel) but prevented a subsequent
application of 100 µM MTSET from having an
effect (center panel). However, after a 1 min
exposure to 1 mM DTT, the robust MTSET-induced
current increase returned (bottom panel). Results
averaged from three such experiments are summarized in Figure
9B and demonstrate that MTSES covalently modifies S273C
without inducing a current magnitude change. A similar protocol
revealed that the R271C mutant GlyR was also modified covalently by 1 mM MTSES (Fig. 9C). By contrast, the
V277C mutant GlyR was inhibited dramatically by 1 mM MTSES, although 100 µM
MTSET had no apparent effect. As shown in Figure 9D,
previous MTSET application protects against the inhibitory effects of
MTSES, demonstrating that MTSET does indeed modify V277C without
changing the current amplitude. Thus, all three sulfhydryl groups
(R271C, S273C, and V277C) are readily accessible to both MTSET and
MTSES.

View larger version (27K):
[in this window]
[in a new window]
|
Figure 9.
Modification of S273C, R271C, and V277C without
effects on current magnitude. A, All
traces in A were recorded sequentially
from the same cell. An application of 1 mM MTSES had no
irreversible effect on current magnitude (top
panel). A subsequent application of 100 µM
MTSET was also without effect (center
panel). However, after a 1 min wash in 1 mM DTT, a large irreversible MTSET-mediated current
increase was observed (bottom panel),
demonstrating MTSES and modification of S273C. B,
Averaged results from three cells using the experimental protocol
displayed in A indicate that MTSET-mediated current
increase was significant before, but not after, MTSES
application. C, Results, averaged from three
cells, of a similar experiment on the R271C mutant GlyR. The
MTSET-mediated current increase was significant before, but not after,
MTSES application. D, Results of a similar experiment on
the V277C mutant GlyR. In this case, a previous MTSET application
prevented MTSES-mediated inhibition. Results were averaged from three
cells.
|
|
As indicated in Figure 8, A272C was the only residue to respond to
MTSES via an increase in glycine sensitivity. The averaged open and
closed state reaction time constants, measured as shown in Figure 6,
were 0.41 ± 0.06 sec (n = 5 cells) and 13.2 ± 3.2 sec (n = 4), respectively. The difference between these
values was statistically significant (p < 0.05). The reaction rates calculated from these time constants are
shown in Figure 8B.
The V277C mutant GlyR averaged open and closed state reaction time
constants of 1.83 ± 0.25 sec (n = 5 cells) and
5.97 ± 0.76 sec (n = 3), respectively, which is a
statistically significant difference (p < 0.05). The mean MTSES modification rate constants calculated from these
values are also shown in Figure 8B. In the K276C
mutant GlyR, the MTSES-induced inhibition was very rapid in both the
closed and open channel states (Fig.
10A,B).
The displayed traces, obtained from different cells, were recorded
using a saturating (15 mM) glycine concentration
and a 500 µM MTSES concentration. Because the
time course of MTSES modification was indistinguishable from
that of the solution exchange (Fig. 10B), the true
modification rate was too fast to be resolved under our experimental
conditions. For this to happen, the MTSES modification rate must have
been >1.3 × 104
M/sec. Higher resolution experiments will
be required to characterize the interaction between MTSES and
K276C.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 10.
Effects of MTSES on K276C and P275C mutant GlyRs.
A, B, Currents activated by a 15 mM (saturating) glycine concentration are rapidly inhibited
by 500 µM MTSES applied in the channel closed state
(A) and in the fully open state
(B). In both cases, a 2 min wash in control
solution reveals that the inhibition is irreversible.
Traces in A and B were
recorded from different cells. The horizontal scale bar
applies to both recordings. C, This trace
was recorded from the same cell as B. After modification
by MTSES, a 2 mM concentration of DTT reversibly activates
a slow inward current. D, A 2 mM
concentration of DTT also reversibly activates a slow inward current in
the MTSES-modified P275C mutant GlyR. In both mutant GlyRs, an inverse
relationship existed between the magnitude of the DTT-activated current
and the glycine-activated current (n = 5 cells
expressing each mutant GlyR).
|
|
Effects of DTT on MTSES-modified GlyRs
As stated above, MTSET modification of all mutant GlyRs examined
in this study was completely reversed by a 1 min exposure to 1 mM DTT. This treatment also completely reversed the effect of MTSES modification of the R271C, A272C, and S273C mutant GlyRs. However, a 1 min exposure to 1 mM DTT did not diminish
significantly the magnitude of MTSES-induced current changes in the
L274C, P275C, K276C, or V277C mutant GlyRs. Indeed, longer (3-5 min)
applications of 2 mM DTT were also without significant
effect (n 7 cells for each of L274C, P275C, K276C,
or V277C). However, 2 mM DTT did exert an unusual
effect on MTSES-modified K276C and P275C mutant GlyRs. An example of
its effect on the K276C mutant GlyR is shown in Figure 10C.
This trace was recorded from the same cell as displayed in Figure
10B. After MTSES exposure, 2 mM
DTT induced a large, slowly activating inward current (Fig.
10C). This current attained a peak magnitude of 1.03 ± 0.16 times (n = 5) the saturating magnitude of the
glycine-activated current before MTSES modification and was activated
with a mean time constant of 11.5 ± 0.9 sec (n = 5).
After removal of DTT, the current gradually returned to baseline. When
the DTT-activated current was maximal, the glycine-activated current
was diminished in magnitude, but after DTT was removed and the current
returned to baseline, the glycine-activated current increased to its
previous MTSES-modified magnitude (Fig. 10C). The
DTT-mediated current could be reproduced multiple times in direct
succession from the same cell, and DTT did not reverse MTSES
modification of K276C. The DTT-mediated current was never observed
before the application of MTSES (n = 7 cells).
A very similar effect was observed with the MTSES-modified P275C mutant
GlyR (Fig. 10D). DTT activated the current with a
time constant of 12.0 ± 3.2 sec (n = 7 cells), and the
current reached a peak magnitude of 4.9 ± 0.6 times (n
= 7 cells) the magnitude of the saturating glycine-activated
current. Again, before the application of 1 mM
MTSES, DTT exerted no detectable effect on current magnitude (n
= 7 cells). This DTT-activated current was the only evidence for
MTSES modification of P275C.
MTSES irreversibly activates the L274C mutant GlyR
The L274C mutant GlyR was irreversibly activated by MTSES. An
example of its effect when applied in the channel open state is shown
in Figure 11A. These
experiments were performed using a 400 µM
(EC50) glycine concentration and a 1 mM MTSES concentration. In the presence of
glycine, the MTSES-mediated current increase followed a time constant
of 499 msec (Fig. 11A). The open state modification
time constant averaged from six cells was 369 ± 79 msec. After
MTSES exposure, the channels remained in a partially activated state,
even after a 5 min wash in 2 mM DTT (n
= 6 cells). A subsequent application of 400 µM glycine fully activated the remaining
fraction of receptors, indicating that MTSES modification had
irreversibly increased the glycine sensitivity (Fig.
11A). A 100 µM concentration
of strychnine completely inhibited current flow through the
MTSES-modified receptors (n = 3 cells). Although 1 mM picrotoxin completely inhibited currents
before the application of MTSES, it had no significant effect on
MTSES-modified receptors (n = 3 cells). An example of the
effect of 1 mM MTSES applied in the channel
closed state is shown in Figure 11B. MTSES directly activated a small inward current at a time constant of 7.73 sec. The time constant averaged from five cells was 9.37 ± 2.1 sec. After MTSES was removed, the current suddenly increased, suggesting that MTSES also exerted an inhibitory effect (Fig.
11B). This unusual effect was observed in all five
cells in which it was examined. Again, the channels remained in the
partially activated state after the MTSES modification. A subsequent
application of 400 µM glycine fully activated
the remaining complement of receptors, indicating that MTSES
modification had increased the glycine sensitivity (Fig.
11B). The averaged MTSES modification rate
constants in the closed and open states are displayed in Figure
7B. The results indicate that the L274C reacts faster with
MTSES in the glycine-bound state.

View larger version (23K):
[in this window]
[in a new window]
|
Figure 11.
MTSES modification of L274C induces irreversible
activation. A, Effect of 1 mM MTSES applied
in the presence of a 400 µM (EC50)
glycine concentration. MTSES modification followed a time constant of
499 msec. After removal of glycine, the channels remained partially
activated. A 5 min application of 2 mM DTT was without
significant effect, and further application of 400 µM and
10 mM indicated an irreversible increase in glycine
sensitivity. B, Effect of 1 mM MTSES applied
in the absence of glycine. Glycine-gated current was monitored using a
400 µM (EC50) or a 10 mM
(saturating) glycine concentration, as indicated. MTSES directly
induced a small, slowly activating current. The magnitude of this
current was rapidly enhanced after the removal of MTSES. Subsequent
applications of 400 µM and 10 mM glycine
indicated an irreversible increase in glycine sensitivity. A 5 min DTT
application was again without significant effect. Traces
displayed in A and B were recorded from
different cells, and each trace is representative of
five cells.
|
|
 |
DISCUSSION |
Considerations for the interpretation of results
By measuring the rates of reaction of charged MTS reagents with
substituted cysteines throughout the M2-M3 loop, this study aimed to
provide evidence for loop conformational changes during channel gating.
However, several important considerations apply to the interpretation
of the reaction rate data.
Many of the cysteine-substitution mutations caused large shifts in the
glycine sensitivity (Fig. 2B). This highlights an
unavoidable problem of using site-directed mutagenesis to investigate
domains involved in receptor gating. The problem is one of reciprocity between ligand-binding sites and allosteric activation pathways. In the
same way that a small ligand binding-induced conformational change in
the ligand-binding site alters the structural orientation of domains
involved in receptor activation, mutating these domains will also
affect apparent ligand-binding affinity (Colquhoun, 1998 ). Thus, a
caveat that must be applied to the findings of this study is that the
mutations themselves may have induced structural alterations in the
M2-M3 loop.
Each functional GlyR contains five introduced cysteines. This study has
not determined how many cysteines per receptor need to be modified to
produce the entire effect. This has important implications for the true
rate of reaction, which in turn may have implications for understanding
the mechanisms of action of the MTS reagents. A related issue concerns
the fact that open state reaction rates were generally measured at the
glycine EC20 value, which would have further
distorted the true open state reaction rate. In this study, conclusions
are based on the differential between the closed and open state
reaction rates, not on their absolute magnitudes.
The rate of reaction of a charged MTS derivative is determined by three
factors: local electrostatic potential, sulfhydryl ionization state,
and steric availability of the sulfhydryl group at the protein surface.
A state-dependent change in electrostatic potential can lead to a
state-dependent difference in the reaction rate of a charged MTS
derivative (Pascual and Karlin, 1998 ). If a state-dependent change in
reaction rate is similar for a positively and a negatively charged MTS
derivative, then a state-dependent change in electrostatic potential is
unlikely. MTS ions react 5 × 109
times faster with ionized cysteines (-S )
than with uncharged thiols (-SH) (Roberts et al., 1986 ). Sulfhydryl ionization is likely to be increased in conditions of higher dielectric constant and increased space for the formation of activated complexes (Pascual and Karlin, 1998 ). Because water has a higher dielectric constant than a nonpolar protein interior, ionization state and steric
availability are both determined by the accessibility of the sulfhydryl
group to the protein surface. Thus, if electrostatic potential can be
eliminated as a determinant of state-dependent changes in reactivity
rates, then changes in surface availability of introduced sulfhydryl
groups will be the dominant factor in controlling MTS reactivity rates.
The M2-M3 domain as an irregular surface loop
Substituted cysteine accessibility studies of the M2 domain of the
nicotinic acetylcholine receptor have shown that protein surface
-helices generally have one exposed cysteine per helix rotation
(Akabas et al., 1994 ; Zhang and Karlin, 1998 ). Similarly, -sheets
may be expected to have every second residue exposed (Akabas et al.,
1992 ; Boileau et al., 1999 ). The observation that the seven contiguous
residues closest to the M2 domain end of the loop are exposed to the
aqueous interface (Fig. 4) is not consistent with either model and
therefore reinforces the current view of this domain as an irregular
loop (Galzi and Changeux, 1995 ; Karlin and Akabas, 1995 ; Rajendra et
al., 1997 ). Because covalent modification of residues from R271C to
P275C by either MTSET or MTSES did not affect the saturating current
magnitude, it is unlikely that single channel conductance was modified.
Therefore, despite linking directly to the M2 domain, it is unlikely
that the loop contributes to the lining of the pore vestibule.
Either the four residues from S278C to K281C were exposed
insufficiently to the surface to permit the access of MTSET or MTSES, or, if they were sufficiently exposed, their modification induced no
dramatic change in receptor function. These residues lie close to the external end of the M3 domain. It has been demonstrated recently
that several M3 domain residues of the GABAAR
1 subunit are exposed to the protein surface, implying that this
domain lines a water-filled crevice that extends deep into the membrane (Williams and Akabas, 1999 ). The water accessibility of this crevice is
increased in the GABA- and benzodiazepine-bound states (Williams and
Akabas, 1999 , 2000 ). Furthermore, because an M2 domain residue and an
M3 domain residue combine to form a water-accessible alcohol and
anesthetic binding site (Mascia et al., 2000 ), this crevice is
apparently lined by elements of both domains.
Evidence for changes in the surface accessibility of the
M2-M3 loop
As shown in Figure 7A, the MTSET reaction rate with all
residues from R271C to K276C was faster in the glycine-bound state than
in the unliganded state. Because the MTSES reaction rates with two of
these residues (A272C and L274C) was also faster in the glycine-bound
state (Fig. 7B), it can be concluded that surface accessibility is the dominant factor influencing the reaction rate. It
was not possible to directly compare MTSET and MTSES modification rates
at any other residue. However, because it is highly unlikely that
electrostatic potential would change drastically from one residue to
the next, it is probable that the MTSET reactivity difference of all
residues from R271C to V277C is dominated by thiol surface
accessibility. Hence, it may be concluded that when glycine binds to
the receptor, these residues become more accessible at the protein surface.
It is not possible, however, to determine whether the M2-M3 loop moves
with respect to static surrounding domains or whether the accessibility
change is caused by the movement of an overlying domain. It is also not
possible to resolve whether the overlying domain lies close enough to
sterically control access to the substituted cysteines or whether a
distant part of the receptor acts as a gate to prevent access to the
entire domain.
Effects of covalent modification
MTSET modification of R271C, A272C, S273C, L274C, and K276C
dramatically increased the apparent glycine affinity (Fig.
5B). MTSES had a similar effect on the A272C mutant GlyR
(Fig. 8). In principle, such effects could result from structural
alterations to the glycine-binding site or to the receptor gating
mechanism. However, because strong evidence implicates the M2-M3 loop
as a transduction element (Kusama et al., 1994 ; Rajendra et al., 1995a ;
Campos-Caro et al., 1996 ; Lynch et al., 1997 ; Fisher and Macdonald,
1998 ; Lewis et al., 1998 ; Rovira et al., 1998 , 1999 ; Boileau and
Czajkowski, 1999 ; Grosman et al., 2000a ,b ), it is likely that MTS
modification primarily affects the gating mechanism. If so, the
increase in ligand affinity indicates a bias in the conformational
equilibrium toward the high-affinity activated state. The irreversible
partial activation of the L274C mutant GlyR by MTSES (Fig. 11) may be
an extreme example of such a mechanism. On the other hand, MTSET
modification of the P275C mutant GlyR decreased the glycine affinity
(Fig. 5B), presumably by biasing the receptor conformation
equilibrium toward the closed state. MTSES modification of the K276C
and V277C mutant GlyRs resulted in a current reduction without an
accompanying change in glycine affinity (Fig. 8), implying that the
modified receptors were hindered from entering a fully conducting state.
MTSET and MTSES frequently induced different effects when applied to
the same residue. For example, at position K276C, MTSET increased the
apparent glycine affinity, whereas MTSES reduced current without
affecting glycine sensitivity. Without knowledge of GlyR tertiary
structure, it is not possible to explain such effects, although some
general principles can be considered. Like any protein structure, the
conformation of the M2-M3 loop is maintained by a combination of Van
der Waals forces: hydrogen bonds and ionic bonds with both water and
neighboring domains. The attached ethyltrimethylammonium and
ethylsulfonate side chains would be expected to affect loop structure
by two mechanisms. First, their bulkiness would distort the local
protein structure, and second, they would introduce additional charges
and hydrogen bond-forming ions. Together, these effects would change
the balance of existing bonding forces or create new ones, leading to
either a change in the local structure or a change in the stability of
the existing structure. Thus, the difference in size, charge, and
chemical properties of ethyltrimethylammonium and ethylsulfonate could
bias the receptor toward various different functional states, leading
to a variety of different phenotypes.
Although DTT efficiently reduced MTSET modification of all responsive
mutants and MTSES modification of R271-S273C, it did not reduce the
MTSES modification of L274C-V277C. Because MTSES is smaller than
MTSET, the MTSES modification of these later residues probably resulted
in a reduced space around the introduced sulfhydryl groups, thereby
hindering DTT accessibility to the disulfide bonds. A surprising
finding was that MTSES modification of P275C and K276C rendered the
GlyRs susceptible to activation by DTT (Fig. 10C,D). Because DTT did not reverse the
MTSES-mediated inhibition of the K276C mutant GlyR, it is unlikely that
the agonist action was mediated by the reduction of K276C. It is more
likely that DTT acts elsewhere on the receptor, possibly by reducing an
endogenous disulfide bond.
An unusual observation was that the L274C mutant GlyR was not affected
by either MTSET or MTSES unless it was first exposed to DTT for 1 min.
As stated above, DTT did not change the glycine sensitivity. One
possibility is that the introduced cysteines in adjacent subunits are
constitutively cross-linked in the naive L274C GlyR. However, because
the resultant conformational restriction should affect the glycine
sensitivity, this possibility is unlikely. Another possibility is that
some component of the cell culture medium may have chemically modified
the introduced cysteines at this position. Additional experiments are
required to determine why the naive L274C GlyR is insensitive to MTS reagents.
When the L274C mutant GlyR was irreversibly activated by MTSES, the
resultant current was not affected by 1 mM picrotoxin but
was completely inhibited by 100 µM strychnine. Picrotoxin behaves as a potent competitive antagonist of the WT GlyR 1 subunit (Lynch et al., 1995 ). However, picrotoxin almost certainly acts via an
allosteric mechanism because mutations to R271 convert it into a
noncompetitive antagonist at high picrotoxin concentrations and into an
allosteric potentiator at low concentrations (Lynch et al., 1995 ). The
loss of picrotoxin sensitivity in the MTSES-modified L274C mutant GlyR
is therefore not surprising given that mutations to a nearby residue
drastically affect its mode of action. However, much evidence
implicates strychnine as a classical competitive antagonist of the GlyR
(for review, see Rajendra et al., 1997 ). The observation that extremely
high (100 µM) strychnine concentrations inhibit an
irreversibly activated GlyR in the absence of glycine suggests that
strychnine may also act via a distinct mechanism. Additional
experiments are required to investigate this novel mechanism of action.
Comparison with other studies
It has been demonstrated previously that genetic mutations causing
human startle disease (Rajendra et al., 1995a ; Lynch et al., 1997 ;
Lewis et al., 1998 ; Saul et al., 1999 ) and numerous alanine-substituted
mutations in both the M1-M2 and the M2-M3 loops (Lynch et al., 1997 )
functionally disrupt the linkage between the GlyR agonist-binding sites
and the activation gate. From this it was inferred that the loops were
components of the receptor gating process. Recent evidence from the
nicotinic acetylcholine receptor cation channel (Campos-Caro et al.,
1996 ; Rovira et al., 1998 , 1999 ; Grosman et al., 2000a ,b ), the
GABAc receptor Cl
channel (Kusama et al., 1994 ), and the GABAA
receptor Cl channel (Fisher and
Macdonald, 1998 ; Boileau and Czajkowski, 1999 ) suggests that this
domain also comprises a gating control element in other members of the
ligand-gated ion channel superfamily. By demonstrating that the surface
accessibility of the M2-M3 loop is increased in the glycine-bound
state, the present study provides evidence for an external
conformational change that accompanies channel activation and places
constraints on structural models of ligand-gated ion channels.
 |
FOOTNOTES |
Received Nov. 28, 2000; revised Jan. 17, 2001; accepted Jan. 26, 2001.
This work was supported the Australian Research Council (J.W.L.) and
the National Health and Medical Research Council of Australia (P.R.S.).
N.-L.R.H. was the recipient of an International Postgraduate Research
Studentship from the Australian Commonwealth Department of Education,
Training and Youth Affairs.
Correspondence should be addressed to Dr. Joseph Lynch, Department of
Physiology and Pharmacology, University of Queensland, Brisbane, QLD,
4072, Australia. E-mail: lynch{at}plpk.uq.edu.au.
 |
REFERENCES |
-
Akabas MH,
Stauffer DA,
Xu M,
Karlin A
(1992)
Acetylcholine receptor structure probed in cysteine-substitution mutants.
Science
258:307-310[Abstract/Free Full Text].
-
Akabas MH,
Kaufmann C,
Archdeacon P,
Karlin A
(1994)
Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the
subunit.
Neuron
13:919-927[Web of Science][Medline]. -
Boileau AJ,
Czajkowski C
(1999)
Identification of transduction elements for benzodiazepine modulation of the GABAA receptor: three residues are required for allosteric coupling.
J Neurosci
19:10213-10220[Abstract/Free Full Text].
-
Boileau AJ,
Evers AR,
Davis AF,
Czajkowski C
(1999)
Mapping the agonist binding site of the GABAA receptor: evidence for a
-strand.
J Neurosci
19:4847-4854[Abstract/Free Full Text]. -
Campos-Caro A,
Sala S,
Balesta JJ,
Vicente-Agullo F,
Criado M,
Sala F
(1996)
A single residue in the M2-M3 loop is a major determinant of coupling between binding and gating in neuronal nicotinic receptors.
Proc Natl Acad Sci USA
93:6118-6123[Abstract/Free Full Text].
-
Chen C,
Okayama H
(1987)
High efficiency expression of mammalian cells by plasmid DNA.
Mol Cell Biol
7:2745-2751[Abstract/Free Full Text].
-
Colquhoun D
(1998)
Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors.
Br J Pharmacol
125:924-947[Web of Science][Medline].
-
Elmslie FV,
Hutchings SM,
Spencer V,
Curtis A,
Covanis T,
Gardiner RM,
Rees M
(1996)
Analysis of GLRA1 in hereditary and sporadic hyperekplexia: a novel mutation in a family cosegregating for hyperekplexia and spastic paraparesis.
J Med Genet
33:435-436[Abstract/Free Full Text].
-
Fisher JL,
Macdonald RL
(1998)
The role of an
subtype M2-M3 His in regulating inhibition of GABAA receptor current by zinc and other divalent cations.
J Neurosci
18:2944-2953[Abstract/Free Full Text]. -
Galzi J-L,
Changeux JP
(1995)
Neuronal nicotinic receptors: molecular organization and regulations.
Neuropharmacology
34:563-582[Web of Science][Medline].
-
Grosman C,
Salamone FN,
Sine SM,
Auerbach A
(2000a)
The extracellular linker of muscle acetylcholine receptor channels is a gating control element.
J Gen Physiol
116:327-339[Abstract/Free Full Text].
-
Grosman C,
Zhou M,
Auerbach A
(2000b)
Mapping the conformational wave of acetylcholine receptor channel gating.
Nature
403:773-776[Medline].
-
Karlin A,
Akabas MH
(1995)
Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins.
Neuron
15:1231-1244[Web of Science][Medline].
-
Karlin A,
Akabas MH
(1998)
Substituted-cysteine accessibility method.
Methods Enzymol
293:123-145[Web of Science][Medline].
-
Kusama T,
Wang JB,
Spivak CE,
Uhl GR
(1994)
Mutagenesis of the GABA
1 receptor alters agonist affinity and channel gating.
NeuroReport
5:1209-1212[Web of Science][Medline]. -
Lewis TM,
Sivilotti LG,
Colquhoun D,
Gardiner RM,
Schoepfer R,
Rees M
(1998)
Properties of human glycine receptors containing the hyperekplexia mutation alpha1(K276E), expressed in Xenopus oocytes.
J Physiol (Lond)
507:25-40[Abstract/Free Full Text].
-
Lynch JW,
Rajendra S,
Barry PH,
Schofield PR
(1995)
Mutations affecting the glycine receptor agonist transduction mechanism convert the competitive antagonist, picrotoxin, into an allosteric potentiator.
J Biol Chem
270:13799-13806[Abstract/Free Full Text].
-
Lynch JW,
Rajendra S,
Pierce KD,
Handford CA,
Barry PH,
Schofield PR
(1997)
Identification of intracellular and extracellular domains mediating signal transduction in the inhibitory glycine receptor chloride channel.
EMBO J
16:110-120[Web of Science][Medline].
-
Mascia MP,
Trudell JR,
Harris RA
(2000)
Specific binding sites for alcohols and anesthetics on ligand-gated channels.
Proc Natl Acad Sci USA
97:9305-9310[Abstract/Free Full Text].
-
Pascual JM,
Karlin A
(1998)
State-dependent accessibility and electrostatic potential in the channel of the acetylcholine receptor: inferences from rates of reaction with thiosulfonates with substituted cysteines in the M2 segment of the alpha subunit.
J Gen Physiol
111:717-739[Abstract/Free Full Text].
-
Rajendra S,
Lynch JW,
Pierce KD,
French CR,
Barry PH,
Schofield PR
(1995a)
Mutation of an arginine residue in the human glycine receptor transforms
-alanine and taurine from agonists into competitive antagonists.
Neuron
14:169-175[Web of Science][Medline]. -
Rajendra S,
Vandenberg RJ,
Pierce KD,
Cunningham AM,
French PW,
Barry PH,
Schofield PR
(1995b)
The unique extracellular disulfide loop of the glycine receptor is a principal ligand binding element.
EMBO J
14:2987-2998[Web of Science][Medline].
-
Rajendra S,
Lynch JW,
Schofield PR
(1997)
The glycine receptor.
Pharmacol Ther
73:121-146[Web of Science][Medline].
-
Rees MI,
Andrew M,
Jawad S,
Owen MJ
(1994)
Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the
1 subunit of the inhibitory glycine receptor.
Hum Mol Genet
3:2175-2179[Abstract/Free Full Text]. -
Roberts DD,
Lewis SD,
Ballou DP,
Olson ST,
Shafer JA
(1986)
Reactivity of small thiolate anions and cysteine-25 in papain toward methyl methanethiosulfonate.
Biochemistry
25:5595-5601[Medline].
-
Rovira JC,
Ballesta JJ,
Vicente-Agullo F,
Campos-Caro A,
Criado M,
Sala F,
Sala S
(1998)
A residue in the middle of the M2-M3 loop of the beta 4 subunit specifically affects gating of neuronal nicotinic receptors.
FEBS Lett
433:89-92[Web of Science][Medline].
-
Rovira JC,
Vicente-Agullo F,
Campos-Caro A,
Criado M,
Sala F,
Sala S,
Ballesta JJ
(1999)
Gating of alpha3beta4 neuronal nicotinic receptor can be controlled by the M2-M3 loop of both alpha3 and beta4 subunits.
Pflügers Arch
439:86-92[Web of Science][Medline].
-
Saul B,
Kuner T,
Sobetzko D,
Brune W,
Hanefield F,
Meinck HM,
Becker CM
(1999)
Novel GLRA1 missense mutation (P250T) in dominant hyperekplexia defines an intracellular determinant of glycine receptor channel gating.
J Neurosci
19:869-877[Abstract/Free Full Text].
-
Shiang R,
Ryan SG,
Zhu YZ,
Hahn AF,
O'Connell P,
Wasmuth JJ
(1993)
Mutations in the
1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia.
Nat Genet
5:351-358[Web of Science][Medline]. -
Shiang R,
Ryan SG,
Zhu YZ,
Fielder TJ,
Allen RJ,
Fryer A,
Yamashita S,
O'Connell P,
Wasmuth JJ
(1995)
Mutational analysis of familial and sporadic hyperekplexia.
Ann Neurol
38:85-91[Web of Science][Medline].
-
Stauffer DA,
Karlin A
(1994)
Electrostatic potential of the acetylcholine binding sites in the nicotinic receptor probed by reactions of binding-site cysteines with charged methanethiosulfonates.
Biochemistry
33:6840-6849[Medline].
-
Williams DB,
Akabas MH
(1999)
-aminobutyric acid increases the water accessibility of M3 membrane-spanning segment residues in -aminobutyric acid type A receptors.
Biophys J
77:2563-2574[Web of Science][Medline]. -
Williams DB,
Akabas MH
(2000)
Benzodiazepines induce a conformational change in the region of the
-aminobutyric acid type A receptor 1-subunit M3 membrane-spanning domain.
Mol Pharmacol
58:1129-1136[Abstract/Free Full Text]. -
Zhang H,
Karlin A
(1998)
Contribution of the
subunit M2 segment to the ion-conducting pathway of the acetylcholine receptor.
Biochemistry
37:7952-7964[Medline].
Copyright © 2001 Society for Neuroscience 0270-6474/01/2182589-11$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
S. A. Pless, M. I. Dibas, H. A. Lester, and J. W. Lynch
Conformational Variability of the Glycine Receptor M2 Domain in Response to Activation by Different Agonists
J. Biol. Chem.,
December 7, 2007;
282(49):
36057 - 36067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Paas, G. Gibor, R. Grailhe, N. Savatier-Duclert, V. Dufresne, M. Sunesen, L. P. de Carvalho, J.-P. Changeux, and B. Attali
Pore conformations and gating mechanism of a Cys-loop receptor
PNAS,
November 1, 2005;
102(44):
15877 - 15882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hawthorne and J. W. Lynch
A Picrotoxin-specific Conformational Change in the Glycine Receptor M2-M3 Loop
J. Biol. Chem.,
October 28, 2005;
280(43):
35836 - 35843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-Q. Hu and D. M Lovinger
Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+
J. Physiol.,
October 15, 2005;
568(2):
381 - 396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Reeves, M. Jansen, M. Bali, T. Lemster, and M. H. Akabas
A Role for the {beta}1-{beta}2 Loop in the Gating of 5-HT3 Receptors
J. Neurosci.,
October 12, 2005;
25(41):
9358 - 9366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Jones-Davis, L. Song, M. J. Gallagher, and R. L. Macdonald
Structural Determinants of Benzodiazepine Allosteric Regulation of GABAA Receptor Currents
J. Neurosci.,
August 31, 2005;
25(35):
8056 - 8065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jung, M. H. Akabas, and R. A. Harris
Functional and Structural Analysis of the GABAA Receptor {alpha}1 Subunit during Channel Gating and Alcohol Modulation
J. Biol. Chem.,
January 7, 2005;
280(1):
308 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Lynch
Molecular Structure and Function of the Glycine Receptor Chloride Channel
Physiol Rev,
October 1, 2004;
84(4):
1051 - 1095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. A. Lobo, M. P. Mascia, J. R. Trudell, and R. A. Harris
Channel Gating of the Glycine Receptor Changes Accessibility to Residues Implicated in Receptor Potentiation by Alcohols and Anesthetics
J. Biol. Chem.,
August 6, 2004;
279(32):
33919 - 33927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cascio
Structure and Function of the Glycine Receptor and Related Nicotinicoid Receptors
J. Biol. Chem.,
May 7, 2004;
279(19):
19383 - 19386.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N.-L. R. Han, J. D. Clements, and J. W. Lynch
Comparison of Taurine- and Glycine-induced Conformational Changes in the M2-M3 Domain of the Glycine Receptor
J. Biol. Chem.,
May 7, 2004;
279(19):
19559 - 19565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Absalom, T. M. Lewis, and P. R. Schofield
Mechanisms of channel gating of the ligand-gated ion channel superfamily inferred from protein structure
Exp Physiol,
March 1, 2004;
89(2):
145 - 153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Dodier, U. Banderali, H. Klein, O. Topalak, O. Dafi, M. Simoes, G. Bernatchez, R. Sauve, and L. Parent
Outer Pore Topology of the ECaC-TRPV5 Channel by Cysteine Scan Mutagenesis
J. Biol. Chem.,
February 20, 2004;
279(8):
6853 - 6862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Absalom, T. M. Lewis, W. Kaplan, K. D. Pierce, and P. R. Schofield
Role of Charged Residues in Coupling Ligand Binding and Channel Activation in the Extracellular Domain of the Glycine Receptor
J. Biol. Chem.,
December 12, 2003;
278(50):
50151 - 50157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Shan, J. L. Haddrill, and J. W. Lynch
Comparative Surface Accessibility of a Pore-lining Threonine Residue (T6') in the Glycine and GABAA Receptors
J. Biol. Chem.,
November 15, 2002;
277(47):
44845 - 44853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Bera, M. Chatav, and M. H. Akabas
GABAA Receptor M2-M3 Loop Secondary Structure and Changes in Accessibility during Channel Gating
J. Biol. Chem.,
November 1, 2002;
277(45):
43002 - 43010.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|